Vestor Capital LLC Has $9,332,000 Stake in UnitedHealth Group Inc. (UNH)
Vestor Capital LLC reduced its position in UnitedHealth Group Inc. (NYSE:UNH) by 23.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 66,094 shares of the healthcare conglomerate’s stock after selling 20,090 shares during the period. UnitedHealth Group comprises approximately 2.6% of Vestor Capital LLC’s investment portfolio, making the stock its 7th largest position. Vestor Capital LLC’s holdings in UnitedHealth Group were worth $9,332,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of UNH. MCF Advisors LLC increased its stake in UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its stake in UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares in the last quarter. Feltz Wealth PLAN Inc. purchased a new stake in UnitedHealth Group during the second quarter worth approximately $143,000. Finally, Evanson Asset Management LLC purchased a new stake in UnitedHealth Group during the second quarter worth approximately $201,000. Institutional investors own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 0.687% during trading on Wednesday, reaching $138.415. The company had a trading volume of 1,349,604 shares. The firm has a market capitalization of $131.83 billion, a PE ratio of 21.661 and a beta of 0.57. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48. The firm has a 50-day moving average of $139.00 and a 200 day moving average of $135.11.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The firm earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. Analysts expect that UnitedHealth Group Inc. will post $7.92 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were issued a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.82%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
A number of research firms recently commented on UNH. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, June 10th. Leerink Swann restated an “outperform” rating and set a $165.00 price objective (up from $155.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. FBR & Co restated an “outperform” rating and set a $155.00 price objective (up from $145.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective on the stock in a research report on Friday, July 22nd. Finally, Oppenheimer Holdings Inc. restated an “outperform” rating and set a $161.00 price objective (up from $145.00) on shares of UnitedHealth Group in a research report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $154.96.
In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.65% of the stock is currently owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.